Blood test may spot lung cancer early
NCT ID NCT07182214
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study is looking at whether a blood test (called a liquid biopsy) can help detect lung cancer. Researchers will collect blood samples from 1,340 people, some with lung nodules and some without, to measure specific molecules called miRNA and DNA methylation. The goal is to see if these markers can tell the difference between people who have lung cancer and those who don't.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to a simple blood test to help detect lung cancer earlier, potentially improving outcomes.
- What could go wrong
- This is an early observational study, not a treatment trial. It may not prove the test is accurate enough for widespread use.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUNG CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Pharus Taiwan, Inc.
RECRUITINGHsinchu, Taiwan
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a simple CT scan catch lung cancer earlier in kuwait?
- Can a new drug combo revive Immunotherapy's power against resistant tumors?
- Seeing the fight: new imaging tracer may reveal how immune cells attack lung cancer
- Your Tumor's DNA might predict immunotherapy success
- Can a new PET tracer light up hidden cancers?
- Fellow veterans may hold the key to earlier lung cancer detection